Holders — by stockHoldings — by fund
Lagoda Investment Management, L.P.
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 1632108
$181.9M
disclosed book value
25
positions
20.6%
largest position share
Positions, as of 2026-06-30
top 25 of 25 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | TPLTEXAS PACIFIC LAND CORPORATI | 85,631 | $37.5M | 20.6% |
| 2 | NTRANATERA INC | 58,503 | $15.9M | 8.7% |
| 3 | TSMTAIWAN SEMICONDUCTOR MANUFAC | 27,520 | $13.1M | 7.2% |
| 4 | GOOGALPHABET INC | 36,375 | $12.9M | 7.1% |
| 5 | AMDADVANCED MICRO DEVICES INC | 17,825 | $10.4M | 5.7% |
| 6 | ARMARM HOLDINGS PLC | 28,525 | $10.1M | 5.6% |
| 7 | DMRCDIGIMARC CORP | 1.1M | $9.4M | 5.2% |
| 8 | XPOXPO INC | 41,890 | $8.6M | 4.7% |
| 9 | STXSSTEREOTAXIS INC | 4.1M | $7.1M | 3.9% |
| 10 | RENAISSANCERE HLDGS LTD | 22,235 | $7.0M | 3.9% |
| 11 | GXOGXO LOGISTICS INCORPORATED | 129,310 | $6.6M | 3.6% |
| 12 | TMDXTRANSMEDICS GROUP INC | 97,465 | $6.5M | 3.6% |
| 13 | GHGUARDANT HEALTH INC | 37,365 | $5.6M | 3.1% |
| 14 | PTCPTC INC | 45,660 | $5.2M | 2.9% |
| 15 | SNPSSYNOPSYS INC | 10,626 | $4.7M | 2.6% |
| 16 | UIUBIQUITI INC | 6,646 | $3.5M | 2% |
| 17 | QXOQXO INC | 203,675 | $3.5M | 1.9% |
| 18 | PROFPROFOUND MED CORP | 501,325 | $3.3M | 1.8% |
| 19 | MAMASTERCARD INCORPORATED | 4,735 | $2.4M | 1.3% |
| 20 | HEIHEICO CORP NEW | 6,000 | $2.1M | 1.2% |
| 21 | VNRXVOLITIONRX LTD | 1.5M | $2.0M | 1.1% |
| 22 | TRUPTRUPANION INC | 79,050 | $2.0M | 1.1% |
| 23 | BRK/BBERKSHIRE HATHAWAY INC DEL | 3,670 | $1.8M | 1% |
| 24 | MSFTMICROSOFT CORP | 1,075 | $400,997 | 0.2% |
| 25 | GLDSPDR GOLD TR | 700 | $257,866 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.